Angiopoietin-1 (Ang-1), which promotes endothelial survival, is reduced in SSc, whereas angiopoietin-2 (Ang-2), a factor disrupting endothelial integrity, is significantly upregulated. Here, ANGPT2 is linked to systemic sclerosis.